AngioDynamics, Inc. (ANGO) financial statements (2022 and earlier)

Company profile

Business Address 14 PLAZA DRIVE
LATHAM, NY 12110
State of Incorp. DE
Fiscal Year End May 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2021
TTM
5/31/2021
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments34,29148,16154,435227,64175,41348,75933,986
Cash and cash equivalents34,29148,16154,435227,64174,09647,54432,333
Short-term investments    1,3171,2151,653
Receivables38,20535,40531,26343,57739,40144,52352,867
Inventory, net of allowances, customer advances and progress billings48,18348,61459,90540,07148,91654,50655,370
Inventory48,18348,61459,90540,07148,91654,50655,370
Prepaid expense 2,0282,4842,4022,6393,2193,013
Other undisclosed current assets11,5066,6714,8261,6011,6632,9071,018
Total current assets:132,185140,879152,913315,292168,032153,914146,254
Noncurrent Assets
Property, plant and equipment43,09037,07328,31224,25842,46145,23448,284
Intangible assets, net (including goodwill)366,709370,293397,651493,053491,562506,927527,829
Goodwill201,709201,316200,515347,666361,252361,252361,252
Intangible assets, net (excluding goodwill)165,000168,977197,136145,387130,310145,675166,577
Other noncurrent assets12,11913,19315,3383,8353,4171,8864,696
Total noncurrent assets:421,918420,559441,301521,146537,440554,047580,809
TOTAL ASSETS:554,103561,438594,214836,438705,472707,961727,063
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities51,90655,08948,47661,16750,20156,89137,558
Accounts payable24,19119,63019,09622,82915,77518,08715,616
Accrued liabilities27,71535,45929,38038,33834,42638,80421,896
Taxes payable      46
Debt   7,5005,0005,00016,250
Business combination, contingent consideration, liability  8364,6352,1009,62512,919
Other liabilities2,5692,4952,133    
Total current liabilities:54,47557,58451,44573,30257,30171,51666,727
Noncurrent Liabilities
Long-term debt and lease obligation31,0117,31948,345124,40786,62191,320105,160
Long-term debt, excluding current maturities25,000 40,000124,40786,62191,320105,160
Operating lease, liability6,0117,3198,345
Liabilities, other than long-term debt24,26624,44223,8409,3721,7823,98626,264
Other liabilities7,7268,7019,029521621850908
Business combination, contingent consideration, liability16,54015,74114,8118,8511,1613,13625,356
Other undisclosed noncurrent liabilities11,98332,63615,71214,54217,17326,11221,684
Total noncurrent liabilities:67,26064,39787,897148,321105,576121,418153,108
Total liabilities:121,735121,981139,342221,623162,877192,934219,835
Stockholders' equity
Stockholders' equity attributable to parent432,368439,457454,872614,815542,595515,027507,228
Common stock379377374372370367363
Treasury stock, value(5,714)(5,714)(5,714)(5,714)(5,714)(5,714)(2,104)
Additional paid in capital580,330573,507561,871555,040543,762532,705525,775
Accumulated other comprehensive income (loss)4,5623,153(1,341)(1,352)(952)(1,324)(791)
Retained earnings (accumulated deficit)(147,189)(131,866)(100,318)66,4695,129(11,007)(16,015)
Total stockholders' equity:432,368439,457454,872614,815542,595515,027507,228
TOTAL LIABILITIES AND EQUITY:554,103561,438594,214836,438705,472707,961727,063

Income statement (P&L) ($ in thousands)

11/30/2021
TTM
5/31/2021
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
Revenues303,275291,010264,157270,634344,285349,643353,890
Revenue, net 349,643353,890
Cost of revenue
(Cost of Goods and Services Sold)
(141,731)(134,222)(113,885)(114,634)(167,410)(173,474)(179,574)
Gross profit:161,544156,788150,272156,000176,875176,169174,316
Operating expenses(203,648)(192,071)(317,370)(165,396)(166,317)(163,202)(173,298)
Operating income (loss):(42,104)(35,283)(167,098)(9,396)10,55812,9671,018
Nonoperating income (expense)(572)92(1,037)(5,306)(3,093)(5,805)(4,271)
Foreign currency transaction loss, before tax     (2,685) 
Other nonoperating income (expense)(525)92(1,037)(5,306)(3,093)(3,120)(4,271)
Interest and debt expense(741)(861)(907)(5,099)(3,062)(2,839)(3,396)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(294) 9075,0993,0625,5243,396
Income (loss) from continuing operations before equity method investments, income taxes:(43,711)(36,052)(168,135)(14,702)7,4659,847(3,253)
Other undisclosed income from continuing operations before income taxes174      
Income (loss) from continuing operations before income taxes:(43,537)(36,052)(168,135)(14,702)7,4659,847(3,253)
Income tax expense (benefit)5,2024,5041,3483,5568,870(4,839)(40,337)
Net income (loss):(38,335)(31,548)(166,787)(11,146)16,3355,008(43,590)
Other undisclosed net income attributable to parent   72,486   
Net income (loss) available to common stockholders, diluted:(38,335)(31,548)(166,787)61,34016,3355,008(43,590)

Comprehensive Income ($ in thousands)

11/30/2021
TTM
5/31/2021
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
Net income (loss):(38,335)(31,548)(166,787)(11,146)16,3355,008(43,590)
Other comprehensive income (loss)2,6284,49411(400)372(533)42
Comprehensive income (loss), net of tax, attributable to parent:(35,707)(27,054)(166,776)(11,546)16,7074,475(43,548)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: